Number of the records: 1  

sorafenib

  1. Record numberd000077157
    Date06.06.2025
    TypeM - MESH
    Topical termsorafenib
    Other termSlovak (Pseudonym) Nexavar
    Slovak (Pseudonym) sorafenib N-oxid
    Slovak (Pseudonym) sorafenib tozylát
    See also(Skutočné meno) antineoplastiká
    (Skutočné meno) inhibítory proteínkináz
    UDCD02.065.950.681.757D02.455.426.559.389.703.757D03.066.515.530.750D03.383.725.547.530.750
    NoteA niacinamide and phenylurea derivative that inhibits multiple intracellular and cell surface kinases thought to be involved in ANGIOGENESIS, including RAF KINASES and VEGF RECEPTORS. It is used in the treatment of advanced RENAL CELL CARCINOMA and HEPATOCELLULAR CARCINOMA, and for treatment of THYROID CARCINOMA refractory to radioactive iodine therapy.
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all